D-hBD3 Alleviates Periodontitis and Systemic Inflammation via a Gut–Oral Axis through Dectin-1-Associated Modulation of Microbial Tryptophan Metabolism
Periodontitis causes alveolar bone loss, systemic inflammation, and gut dysbiosis, which are poorly resolved by conventional local therapies. Oral gavage of D-enantiomeric human β-defensin 3 (D-hBD3) sustains intestinal homeostasis and ameliorates periodontitis, yet the detailed mechanisms remain unclear. This study provides supporting evidence for a plausible gut–oral axis mechanism underlying D-hBD3-mediated periodontitis protection. A ligature-induced mouse periodontitis model was utilized to assess therapeutic outcomes of D-hBD3 oral gavage, D-hBD3 combined with a Dectin-1 antagonist, and fecal microbiota transplantation. Evaluations covered alveolar bone loss, serum lipopolysaccharide and interleukin-6 levels, and intestinal barrier integrity. Intestinal macrophage polarization, tight junction protein expression, and gut microbiota composition were analyzed, while multi-omics and correlation analyses characterized host and microbial tryptophan metabolic alterations and core regulatory molecules. D-hBD3 treatment and microbiota transplantation reduced alveolar bone resorption, restored intestinal barrier integrity, and alleviated systemic inflammation. Pharmacological Dectin-1 inhibition partially abolished these protective effects, supporting the involvement of Dectin-1 signaling in this protective phenotype. D-hBD3 activates intestinal macrophage Dectin-1 signaling, promotes M2 polarization, and upregulates tight junction proteins, thereby remodeling gut microbiota by enriching Bifidobacterium and depleting Akkermansia and Escherichia . D-hBD3 remodels tryptophan metabolism, elevating indole-3-carboxaldehyde and suppressing serotonin pathway metabolites. These microbial ligands positively correlate with Dectin-1 and extracellular matrix remodeling genes and negatively correlate with pro-inflammatory Stat1 . D-hBD3 ameliorates periodontitis via the gut–oral axis through a Dectin-1-associated gut microbiota–tryptophan metabolism cascade, revealing the promising potential of gut-targeted defensins as adjunctive periodontitis therapeutics.
Authors
- Fuhua Yan (ORCID: https://orcid.org/0000-0002-6963-3530)
- Rixin Chen (ORCID: https://orcid.org/0000-0002-3876-735X)
- Can Ni (ORCID: https://orcid.org/0009-0006-5029-9006)
- Yanfen Li
- Miaomiao Zhang
- Di Cui
- Wenrong Yang
- Lingjun Li
- Yuan Wei
Institutions
- Deakin University (AU)
- Nanjing University (CN)
Publication Details
- Journal
- Inflammation
- Published
- 2026-11-20
- DOI
- https://doi.org/10.1007/s10753-026-02654-9
- Primary Topic
- Oral microbiology and periodontitis research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Deakin University